HIGHLIGHTS
- who: Lingling Jiang et al. from the Wenzhou-Kean University, China have published the research: The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium-Resveratrol Conjugate on Breast Cancer Cells, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of 10/06/2022
- what: The authors demonstrate that significantly improved cytotoxicity in 4T1 cells and MDA-MB-231 cells by inducing apoptosis and mitochondrial membrane potential loss. The authors used LC/MS-based global metabolic profiling to investigate the effects of resveratrol and TPP-resveratrol on breast cancer cells.
- how: The results indicated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.